Torsade de pointes induced by short-term oral amiodarone therapy

Europace

Volumn 8, Issue 12, 2006, Pages 1051-1053

  Lim, Hong Euy ^a   Pak, Hui Nam ^a   Ahn, Jeong Cheon ^a   Song, Woo Hyuk ^a   Kim, Young Hoon ^a  

^a Korea University   (South Korea)

Author keywords

Amiodarone; QT prolongation; Torsade de pointes

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMLODIPINE; CANDESARTAN; ISOPRENALINE; MAGNESIUM SULFATE;

ADULT; AGED; ARTICLE; CARDIOVERSION; CASE REPORT; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEFIBRILLATION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LOW DRUG DOSE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; SHORT COURSE THERAPY; SINUS BRADYCARDIA; SINUS RHYTHM; TORSADE DES POINTES;

ADMINISTRATION, ORAL; ADULT; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOMYOPATHIES; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; SYNCOPE; TIME FACTORS; TORSADES DE POINTES;

EID: 33845380293     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eul118     Document Type: Article

References (7)

1. Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med 1994;121:529-35.
2. Yamada S, Kuga K, Yamaguchi I. Torsade de pointes induced by intravenous and long-term oral amiodarone therapy in a patient with dilated cardiomyopathy. Jpn Circ J 2001;65:236-8.
3. Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone. Pacing Clin Electrophysiol 2005;28:472-3.
4. Podrid PJ. Amiodarone: Reevaluation of an old drug. Ann Intern Med 1995;122:689-700.
5. Nattel S, Talajic M, Quantz M, DeRoode M. Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: Evidence for calcium channel blocking activity. Circulation 1987;76:442-9.
6. Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 1992;86:1376-82.
7. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long QT syndrome: Clinical impact. Circulation 1999;99:529-33.